Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder
ICD-10 F13.280 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder.
F13.280 refers to a condition characterized by the dependence on sedative, hypnotic, or anxiolytic substances, which leads to the development of an anxiety disorder induced by these substances. Patients with this diagnosis often exhibit a pattern of compulsive use of medications such as benzodiazepines or barbiturates, which can result in tolerance and withdrawal symptoms. The induced anxiety disorder manifests as heightened anxiety levels that occur during periods of intoxication or withdrawal from these substances. Clinically, this condition can complicate treatment approaches, as the anxiety symptoms may be exacerbated by the very substances intended to alleviate anxiety. Effective management typically requires a multidisciplinary approach, including detoxification, psychotherapy, and possibly the use of alternative medications to address both the dependence and the anxiety disorder. Understanding the interplay between substance use and mental health is crucial for effective treatment and recovery.
Detailed history of substance use, mental health evaluations, and treatment plans.
Patients presenting with anxiety symptoms during withdrawal or while on sedatives.
Need for careful monitoring of withdrawal symptoms and potential for relapse.
Comprehensive assessment of substance use patterns and co-occurring mental health disorders.
Patients seeking treatment for substance dependence with concurrent anxiety issues.
Integration of behavioral therapies and pharmacotherapy in treatment plans.
Used for follow-up visits in patients with sedative dependence and anxiety.
Document the patient's history, mental status examination, and treatment plan.
Psychiatric evaluations may require additional documentation of mental health assessments.
F13.280 includes the presence of an induced anxiety disorder due to sedative dependence, while F13.10 refers to dependence without withdrawal or induced anxiety.
